<DOC>
	<DOC>NCT00754715</DOC>
	<brief_summary>The primary purpose of this study is to assess the safety and tolerability of AZD2516 following administration of a single dose.</brief_summary>
	<brief_title>Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD2516 to Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy white males or nonfertile females between 20 to 45 years and 65 to 80 years old. Weight between 50 to 100 kg and a body mass index (BMI) between 19 to 28 kg/m2 History of previous or ongoing psychiatric disease. Abnormalities in ECG that may interfere with interpretation of data.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Multiple dosing study,</keyword>
	<keyword>safety</keyword>
</DOC>